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AnalgesicAbstract Echinacea is used ethnomedicinally for the treatment of various diseases such as cough,
respiratory infections, and bronchitis among other uses in Eastern Cape region of South Africa.
This study evaluated the volatile components of the essential oil of the plant, its toxicity, anti-
inflammatory and analgesic activities in rodents.
Dried leaf and root of the plant were separately processed by hydrodistillation for 4 h and their
essential oils (EOs) were collected. Extracted oils were subjected to GC/GC–MS analysis. The
essential oil was further evaluated for acute toxicity, anti-inflammatory and analgesic activities.
The toxicity profile of the essential oil was evaluated in mice through the oral route (p.o.), and
anti-inflammatory activity was evaluated on the carrageenan-induced edema model in rats at the
doses of 100–200 mg/kg, while its analgesic effect was evaluated on the acetic acid-induced wri-
things model in mice at doses of 100–200 mg/kg.
GC/GC–MS analysis of EOs showed that a number of compounds identified in the leaf and root
oils were 25 and 31 respectively. The chemical compositions of the oils varied and the major com-
pounds identified in the oils include germacrene D, naphthalene, caryophyllene oxide, a-
phellandrene and a-cadinol. The essential root oil did not cause mortality at the highest dose of
5000 mg/kg; hence, its LD50 was estimated to be P5000 mg/kg, p.o. The anti-inflammatory testAfrica.
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Saudi Pharmaceutical Journal (2016), http://results showed that the essential root oil caused significant (p< 0.05–0.01) reduction in edema size
compared to the negative control group on the carrageenan-induced edema and the results for the
analgesic test showed that the essential root oil caused significant (p< 0.05) reduction in number of
writhings at 1000 mg/kg compared to the negative control group.
It is concluded that root and leaf of this Echinacea species contain volatile oils which varied in
their yield and chemical compositions. The essential root oil is non-toxic orally and it demonstrated
significant anti-inflammatory and analgesic activities in laboratory animals.
 2016 Production and hosting by Elsevier B.V. on behalf of King Saud University. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Medicinal plants are plants that are assumed to have healing
properties and often used to treat some illnesses. These medic-
inal plants have been identified and used throughout the
human history, making an impact on both world health and
international trade for treating various diseases such as diar-
rhea, wounds, and dry cough (Van Wyk et al., 1997).
Echinacea also known as purple coneflower is a medicinal
plant that belongs to the Asteraceae family. The plant consists
of more than 19 species with three species of medicinal interest
known as Echinacea purpurea, Echinacea angustifolia and Echi-
nacea pallida. Echinacea has been used for centuries by Native
Americans for the treatment of various diseases (Turner et al.,
2000). Currently, Echinacea is being used to combat bacterial,
viral, protozoan and fungal infections, and as an anti-
inflammatory agent and as a possible chemo preventative
agent (Barnes et al., 2005).
All the three species of medicinal interest of Echinacea con-
tain varying amounts of essential oils in root, leaf, flower and
aerial parts (Mazza et al., 1999). Essential oil of E. purpurea
contains caryophyllene, caryophyllene epoxide, germacrene
D and borneol while that of E. angustifolia and E. pallida con-
tains ketoalkynes and ketoalkenes (Mazza et al., 1999; Hudaib
et al., 2002).
Essential oils have been recognized as therapeutic agents
and widely utilized as potent natural medicinal components
of plants (Djilani and Dicko, 2012). Essential oils are complex
mixtures of volatile constituents frequently containing 20–60
or more individual compounds (Miguel, 2010). Chemical com-
position of a particular species can vary greatly and some fac-
tors that have been identified to be responsible include genetic,
geographical location, climatic changes, growing conditions,
seasonal variation, time of collection etc. among other factors
(Andrade et al., 2011). Common classes of compounds found
in essential oils include hydrocarbons, esters, oxides, lactones,
alcohols, phenols, aldehydes and ketones. These components
have been reported to be responsible for several bio-activities
ascribed to essential oils (De Sousa et al., 2011). In this study
the essential oils of root and leaf of Echinacea were evaluated
for chemical composition and biological activities in order to
determine its contribution to the reported bioactivities of the
plant and to validate its traditional uses in treating some dis-
eases including infections, respiratory diseases and pain-
related ailments.
In the Eastern Cape region of South Africa, Echinacea is a
popular herbal medicine used by the traditional healers to
manage various diseases including wound healing, respiratory
infections, and pain among several others. The dried leaf anda, M. et al., Volatile constituents and b
dx.doi.org/10.1016/j.jsps.2016.09.010root of the E. purpurea species used in this study was supplied
by the Indigenous Knowledge System holder (Mr. Reuben
Matewu) and was among the several medicinal plants submit-
ted for chemical and biological studies for the purpose of ver-
ifying their medicinal efficacies in laboratory animals by our
research group.2. Materials and methods
2.1. Drugs, chemicals and reagents
Acetic acid (BDH Chemical Ltd., Poole, England), diclofenac
potassium (Diclogesic Supreme), aspirin. All chemicals and
reagents were obtained from Sigma–Aldrich Chemical Co.
(St Louis, MO, USA). All the chemicals used including the sol-
vents, were of analytical grade.
2.2. Animals
Mice and rats were obtained from the South African Vaccine
Initiative, Johannesburg, and kept at the Animal Holding
Facility, Zoology Department, WSU. Male and female Wistar
rats (200–300 g) were randomly selected (n= 6), and were
used for the anti-inflammatory test. Male Swiss mice (25–
35 g; n= 6) were also used for the acute toxicity and the anal-
gesic tests. The animals were kept under standard conditions
of temperature and humidity and had free access to rat chow
and water. Food was however withheld overnight prior to
experiments while water was provided ad libitum. This study
was approved by the Department of Higher Education,
WSU, and Ethical Clearance Approval obtained, Walter
Sisulu University Ethics Committee Reference No. DVC
(AA&R) DRD/SREC: Reference No: 31.
2.3. Plant collection
Dried Echinacea root and leaf was supplied by the Herbal
Practitioner (IKS holder) at King William’s town, Eastern
Cape on the 3rd of July, 2014.
2.4. Extraction of the essential oil
Essential oil of the dried leaf (342 g) and root (368 g) of the
plant were obtained by hydrodistillation using the Clevenger-
type apparatus for 4 h (British Pharmacopoeia, 1980). The oils
were separately collected in airtight glass vial containers, and
stored at 4 C (Oyedeji et al., 2006) before analysis. The yieldsiological activities of the leaf and root of Echinacea species from South Africa.
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(0.29% w/w) for the root.
2.5. GC/GC–MS analysis
Analysis of the oils was performed on an Agilent 5973 N Gas
Chromatography - mass spectrometer system operating in EI
mode at 70 eV, equipped with a HP-5 MS fused silica capillary
system with 5% phenylmethylsiloxane stationary phase,
and capillary column parameter was 30 m by 0.25 mm, film
thickness 0.25 lm. The initial temperature of the column was
70 C and was heated to final temperature of 250 C at a rate
of 5 C/min. Helium was used as the carrier gas at a flow rate
of 1 ml/min. The split ratio was 100:1. Scan time was 78 min
with a scanning range of 35–450 amu. One microliter (1 ll)
of the diluted oil (in hexane) was injected for analysis.
n-Alkane of C8 to C30 were run under the same condition
of Kovat indices determination. The constituents were identi-
fied by GC using retention indices compared with those of
literature. The retention indices were determined in relation
to a homologous series of alkanes under the same operating
conditions. The components of the oils were identified by
matching their spectra and retention indices (Kovat Index)
with those of the authentic samples and literature values
(ESO, 2000; Adams, 1989; Joulain, 1988).
3. Biological studies
3.1. Acute toxicity
Essential oil obtained from the root was used for the biological
assessment because its yield was more and it contains more
compounds (from the GC/MS analysis). The essential root
oil was emulsified with Tween 80 to obtain a maximum con-
centration of 5%v/v before administration to the animals.
The acute toxicity of the root oil of the plant was accessed
according to Lorke’s method (Lorke, 1983). This procedure
was divided into 2 phases. The first phase of the test consists
of three sub-groups (n= 3) for each dose level of 10, 100
and 1000 mg/kg. The second phase employed 4 subgroups
(n= 1) per dose level of 1000, 1600, 2900 and 5000 mg/kg
respectively. Immediately after the treatment, each mouse
was placed inside the Plexiglas cage and observed for immedi-
ate effects up to 30 min and thereafter for 24 h for lethal effects
culminating into death. The LD50 of the essential root oil was
estimated as the geometric mean of the lowest dose causing
death and the highest dose causing no death according to the
formula below:
LD50 ¼ pððAÞ  BÞ
where A is the maximum dose producing 0% death and B is
the dose that produces 100% death (Lorke, 1983). From the
result of LD50 the working doses will be determined according
to the equation below:
Working Doses 6 1=2ðLD50Þ3.2. Anti-inflammatory test
Rats were used for the acute inflammation study using car-
rageenan as the phlogistic agent. Animals were divided intoPlease cite this article in press as: Nyalambisa, M. et al., Volatile constituents and b
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et al., 2010). Group I was negative control group (5% Tween
80, 10 ml/kg), groups II and III were Echinacea essential root
oil (100 and 200 mg/kg respectively), while group IV was the
positive control group (aspirin, 100 mg/kg). All treatments
were by oral route (p.o.) one hour prior to injection of
0.1 ml of 2% carrageenan into the sub-plantar surface of the
left hind paw of the rat. Baseline paw was measured prior to
and after 1, 2, 3 and 4 h post injection of the carrageenan using
Vernier Calipers (Yato).
3.3. Analgesic test
Acetic acid-induced writhing test model was used where there
are four groups of six mice.
Group I was negative control group (5% Tween 80, 10 ml/kg),
and groups II and III were Echinacea essential root oil (100
and 200 mg/kg respectively), while group IV was the positive
control group (diclofenac, 100 mg/kg). All treatments were
by oral route (p.o.) one h prior to intraperitoneal injection
of 0.6% acetic acid (10 ml/kg). Number of abdominal constric-
tions or writhings was counted 5 min post acetic acid injection
for a period of 20 min inside the Plexiglas cages. The number
of writhing displayed by each mouse was counted and
recorded (Hajhashemi et al., 2003).
4. Results and discussion
This study determined the chemical composition of the root
and leaf essential oils of Echinacea, and evaluated the root
essential oil for acute toxicity profile, anti-inflammatory and
analgesic activities in rodents. The results obtained showed
that the essential oils obtained contain several compounds
while the root oil was found to be non-toxic, and possess sig-
nificant anti-inflammatory and analgesic activities in labora-
tory animals.
The yields of the essential oils obtained from this Echinacea
species were 0.24 and 0.29% w/w for the leaf and root respec-
tively. In Table 1, the chemical composition of the essential oil
isolated from Echinacea is summarized; from the GC–MS
results it is evident that Echinacea contains various com-
pounds; and major compounds for both the leaf and the root
were Germacrene D, Naphthalene, Caryophyllene oxide,
Cedrol a-Phellandrene, and a-Cadinol. Previous studies
reported that concentrations of dried material of Echinacea
essential oil range from 0.1% to 1.25% w/w depending on
the part of the plant material used (Mazza et al., 1999).
Mistrikova and Vaverkova´ (2006) reported that the essential
oil of E. purpurea species obtained from Slovakia contains
caryophyllene epoxide, caryophyllene and Germacrene D as
the main constituents signifying that the E. purpurea species
being reported here closely resemble that of Slovakia’s. The
results from GC–MS showed that these oils may be useful in
cosmetic and pharmaceutical industries and this justifies the
use of the plant for various ailments by traditional practition-
ers (Herbalists). The presence of these compounds indicates
that the South African Echinacea species closely resemble the
E. purpurea species from other regions of the world (Barnes
et al., 2005; Bauer, 1999).
The acute toxicity test showed that the essential oil of this
plant did not cause mortality at the highest dose of 5000 mg/kg,iological activities of the leaf and root of Echinacea species from South Africa.
Table 1 Essential oil composition of the leaf and root of Echinacea.
RT Compounds % Composition of compound KI
Leaf oil Root oil
3.24 2-Hexenal 0.9 0.3 853
4.83 a-Pinene 2.8 3.7 937
4.92 a–Fenchene – 0.7 949
5.07 Camphene – 2.0 951
6.15 b-Pinene 1.6 1.2 974
6.90 a-Phellandrene 6.9 6.6 1004
7.74 p-Cymene 3.7 2.9 1029
8.31 Limonene 2.3 1.7 1082
10.07 Linalool 1.5 2.7 1089
11.08 Camphor – 3.4 1143
11.94 Isomenthone 0.1 0.5 1159
12.23 Borneol – 2.1 1166
12.93 Lavandulol – 0.5 1168
15.02 p-Cymen-8-ol – 1.2 1183
13.76 a-Terpineol – 0.2 1189
14.24 Naphthalene 7.8 6.4 1192
16.66 Estragole 2.2 3.3 1199
17.24 Trans-Carveol 4.8 2.6 1217
17.99 Cis-Carveol 1.0 1.0 1227
18.50 Carvone 1.0 3.8 1242
18.69 Peperitone 1.8 - 1253
18.98 Thymol – 0.4 1290
19.72 a-Cubebene 1.4 0.9 1351
20.60 b-Cubebene 0.8 0.4 1387
21.16 Methyl eugenol – 0.6 1402
22.03 Caryophyllene 4.5 4.0 1415
22.33 b-Humulene 0.1 - 1442
22.72 Geranyl acetone – 0.2 1452
22.91 a-Humulene 0.6 - 1453
23.08 c-Muurolene 1.2 - 1476
23.47 Germacrene D 18.1 20.3 1482
26.11 Caryophyllene oxide 11.3 12.2 1577
26.28 Viridiflorol 2.9 - 1590
27.25 Cedrol 7.2 10.5 1600
28.95 Ledol – 3.1 1608
29.25 a-Cadinol 9.1 5.9 1653
% Total 93.6 94.1
Table 2 Acute oral toxicity profile of the essential root oil of
Echinacea in mice.
Dose (mg/kg, p.o.) Death patterns after 24 h
Phase 1 (n = 3)
10 0/3
100 0/3
1000 0/3
Phase 2 (n = 1)
1000 0/1
1600 0/1
2900 0/1
5000 0/1
LD50 LD50 =P5000 mg/kg, p.o.
4 M. Nyalambisa et al.p.o. (Table 2), suggesting that it is non-toxic orally and can be
used to explain the widespread and longtime use of this plant
in traditional medicine. Other studies reported that the sidePlease cite this article in press as: Nyalambisa, M. et al., Volatile constituents and b
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very low and the reports showed that Echinacea extracts are
found to possess the acute toxicity in an extremely low level
(Coeugniet et al., 1986).
The essential root oil of Echinacea (100–200 mg/kg) dose-
dependently and significantly (p< 0.05–0.01) reduced the car-
rageenan–induced rat paw edema throughout the 4 h assess-
ment period compared to the negative control group
signifying anti-inflammatory activity (Adzu et al., 2003;
Muhammad et al., 2015). Similarly, aspirin (standard drug)
also caused significant (p< 0.05–0.01) reduction in edema size
throughout the observation period of 4 h (Fig. 2). Previous
antiinflammatory test of the flower essential oil of E. purpurea
obtained from China showed positive result on the egg
albumin-induced rat paw edema (Yu et al., 2013). Thus the
results obtained here corroborated antiinflammatory poten-
tials of Echinacea essential oil previously reported. Echinacea
has wide application in folkloric medicine in managing various
pain-related ailments including rheumatism and wound heal-
ing (Borchers et al., 2000); hence, the present results justify
the use of this plant in treating these diseases. Although theiological activities of the leaf and root of Echinacea species from South Africa.
Germacrene D α-Phellandrene
Naphthalene Caryophyllene 
Caryophyllene oxide
Figure 1 Some major compounds identified in the essential oil of Echinacea leaf and root.
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Figure 2 Effect of Echinacea essential root oil on the car-
rageenan-induced rat paw edema. Results are expressed as Mean
± SEM. VEH, ECH and ASA represent vehicle (5% Tween 80),
Echinacea root essential oil and aspirin respectively. * p< 0.05,
** p< 0.01, statistically different from negative control group
(ANOVA, Dunnett’s).
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Figure 3 Effect of essential oil of Echinacea root on acetic acid-
induced writhing. Results are expressed as Mean ± SEM. VEH,
ECH and DIC represent vehicle (5% Tween 80), Echinacea root
essential oil and diclofenac respectively. * p< 0.05, ** p< 0.01;
statistically different from vehicle group (ANOVA, Dunnett’s).
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use of the infusion extract which is not the pure essential oil,
the present results implied that the volatile component of this
plant contributes majorly to its anti-inflammatory activity.
Future research can focus on isolating and testing the individ-
ual components identified in the essential oil (see Fig. 1).
Acetic acid-induced writhing test is a sensitive model for
peripheral nociception in rodents. The results obtained here
showed that the essential oil caused significant (p< 0.05)
reduction in writhings caused by the acetic acid compared to
the negative group (Fig. 3) suggesting analgesic potential
(Yonglin et al., 2009; Olorunfemi et al., 2012). These results
indicate that this plant may be more effective as an inflamma-
tory than as an analgesic agent that can be used to further jus-
tify its use in inflammatory diseases such as wound healing and
rheumatism.Please cite this article in press as: Nyalambisa, M. et al., Volatile constituents and b
Saudi Pharmaceutical Journal (2016), http://dx.doi.org/10.1016/j.jsps.2016.09.0105. Conclusion
The leaf and root oils of Echinacea are composed of similar
compounds with seven of their major compounds being the
same. Echinacea root oil is non-toxic and it demonstrated sig-
nificant anti-inflammatory and analgesic activities, thus sup-
porting the use of traditional application of this plant by
Herbalists in the Eastern Cape of South Africa to treat some
ailments.
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